SoumitKBasuMDPhD

Hematology • Watertown, MA

Hematologic Oncology

Senior Medical Director, Clinical Development, Affini-T Therapeutics

Join to view full profile

Dr. Basu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Basu's full profile

Already have an account?

Office
Affini-T
100 Forge Rd
Watertown, MA 02472
Is this information wrong?

Summary

Dr. Soumit Basu is a hematologist/oncologist in Louisville, KY. He received his medical degree and PhD from Rutgers Robert Wood Johnson Medical School and has been in practice 16 years. He specializes in clotting disorders, hematologic oncology, and myeloproliferative disorder hematology-oncology.

Education & Training

University of WashingtonFellowship, Hematology and Medical Oncology, 2007 - 2010
Cleveland Clinic FoundationResidency, Internal Medicine, 2004 - 2007
Rutgers Robert Wood Johnson Medical SchoolClass of 2004
UMDNJ - Robert Wood Johnson Medical School & Rutgers UniversityPhD, Biochemistry, 2002
Johns Hopkins UniversityB.S.E., Biomedical Engineering, 1993

Certifications & Licensure

KY State Medical License 2015 - 2025
IN State Medical License 2020 - 2025
OH State Medical License 2020 - 2024
PA State Medical License 2017 - 2024
LA State Medical License 2020 - 2021
WA State Medical License 2007 - 2020
WV State Medical License 2012 - 2016

Publications & Presentations

PubMed

The Impact of a Hematopoietic Cellular Therapy Pharmacist on Clinical and Humanistic Outcomes: A RE-AIM Framework Analysis.
Benjamin Andrick, Lorraine Tusing, Laney K Jones, Yirui Hu, Rachel Sneidman, Christina Gregor, Soumit Basu, Joseph P Lynch, Joseph Vadakara> ;Transplantation and Cellular Therapy. 2022 Jun 1
1 citations
Impact of Diffuse Large B-Cell Lymphoma on Mammography and Bone Density Testing in Women
Rahul Garg, Usha Sambamoorthi, Xi Tan, Soumit K. Basu, Treah Haggerty, Kimberly M. Kelly> ;The Journal of Primary Prevention. 2021 Mar 12
The VR-DCEP regimen rescues mobilization failures and controls refractory disease in multiple myeloma.
Maxwell M. Krem, Samuel B Reynolds, Hamza Hashmi, Suresh Manapuram, Rani Jayswal, Heidi L. Weiss, Timothy Baize, Lindsey R Figg, Soumit K. Basu, Gregory Monohan, Roger...> ;Bone Marrow Transplantation. 2020 Jul 1
2 citations
Impact of diffuse large B-cell lymphoma on visits to different provider specialties among elderly Medicare beneficiaries: challenges for care coordination.
Rahul Garg, Usha Sambamoorthi, Xi Tan, Soumit K. Basu, Treah Haggerty, Kimberly M. Kelly> ;Translational Behavioral Medicine. 2018 May 23
3 citations
A Rare Case of Erdheim-Chester Disease (Non-Langerhans Cell Histiocytosis) with Concurrent Langerhans Cell Histiocytosis: A Diagnostic and Therapeutic Challenge.
Hamza Hashmi, Drew Murray, John C. Greenwell, Marwan Elahi Shaikh, Soumit Basu, Maxwell M. Krem> ;Case Reports in Hematology. 2018 May 16
31 citations
MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signaling.
Jino Park, Soojin Kim, Joongho Joh, Scot C. Remick, Donald M. Miller, Jun Yan, Zeyad Kanaan, Ju Hsien Chao, Maxwell M. Krem, Soumit K. Basu, Shotaro Hagiwara, Lukas Ke...> ;Oncotarget. 2016 Jun 1
7 citations
Breaking and entering into the CNS: clues from solid tumor and nonmalignant models with relevance to hematopoietic malignancies.
Soumit Basu, Scot C. Remick, Manish Monga, Laura F. Gibson> ;Clinical & Experimental Metastasis. 2014 Feb 1
Join now to see all

Press Mentions

Margaret Mary Health Partners with the Christ Hospital for Medical Oncology CareJuly 10th, 2020